Narcolepsy Pathophysiology Integrated: Immunity, Hypocretin Loss, and Brain Network Reconfiguration

Narcolepsy is a rare, debilitating sleep disorder characterized by excessive daytime sleepiness and cataplexy. Its hallmark is the selective loss of hypothalamic hypocretin (HCRT) neurons, which are crucial for stabilizing sleep-wake states. Current treatments primarily manage symptoms, but a deeper understanding of the underlying mechanisms, particularly how immune dysregulation, neuronal loss, and brain network changes interlink, is vital for developing targeted therapies and diagnostic biomarkers. This review addresses the gap by synthesizing these complex interactions into a unified framework.

Researchers conducted a systematic review of literature from 1990 through April 2026, searching PubMed, Web of Science, and Scopus. Key search terms included narcolepsy, hypocretin/orexin, autoimmunity, HLA, T cell, neural circuit, brain network, and functional connectivity. Articles were selected if they were peer-reviewed, in English, and provided mechanistic insights into narcolepsy. The review was structured around a conceptual framework linking immune dysregulation, HCRT neuron loss, sleep-wake circuit imbalance, and large-scale brain network reconfiguration.

The review established a comprehensive framework for narcolepsy pathophysiology, particularly Type 1 narcolepsy. It highlights that genetic susceptibility combined with environmental triggers initiates an immune-mediated attack, leading to the irreversible loss of lateral hypothalamic HCRT neurons. This critical neuronal loss profoundly disrupts sleep-wake circuit homeostasis, specifically upsetting the delicate balance between REM-off and REM-on neurons, which normally regulate sleep stages. Consequently, this imbalance drives significant brain network remodeling and functional instability throughout the brain. These widespread changes in neural circuitry are directly implicated in the clinical manifestations of the disorder.

The integrated framework demonstrates how immune dysregulation, HCRT neuron loss, and subsequent neural circuit remodeling collectively drive the characteristic symptoms of excessive daytime sleepiness, cataplexy, and cognitive impairment in narcolepsy.